Sean M. Crosson

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Novel AAV44.9-Based Vectors Display Exceptional Characteristics for Retinal Gene Therapy”.

Novel AAV44.9-Based Vectors Display Exceptional Characteristics for Retinal Gene Therapy

Molecular Therapy(2020)10.1016/j.ymthe.2020.04.002

N/A

0DataRank · unranked

28 citations

Shreyasi Choudhury, Sean M. Crosson, Giovanni Di Pasquale, Sandra Afione, Russell Mellen +11 more

Development of an AAV-CRISPR-Cas9-based treatment for dominant cone-rod dystrophy 6

Molecular Therapy — Methods & Clinical Development(2023)10.1016/j.omtm.2023.05.020

N/A

0DataRank · unranked

8 citations

Kaitlyn R. Calabro, K. Tyler McCullough, Sean M. Crosson, Alejandro de la Cova, Diego Fajardo +3 more

Production of a p65 fl/fl /LysMCre mouse model with dysfunctional NF-κB signaling in bone marrow-derived macrophages

Innate Immunity(2023)10.1177/17534259231205993

N/A

0DataRank · unranked

1 citations

Jeffrey Fischer, Anthony Peppers, Sean M. Crosson, Manira Rayamajhi, Edward A. Miao +3 more

Engineered AAV capsid transport mutants overcome transduction deficiencies in the aged CNS

Molecular Therapy — Nucleic Acids(2024)10.1016/j.omtn.2024.102332

N/A

0DataRank · unranked

8 citations

Christy M. Kelley, Luis Daniel Bernal-Conde, Kathy Steece‐Collier, David J. Marmion, Marcus Davidsson +4 more

Development of an AAV-based gene therapy for the ocular phenotype of Friedreich’s ataxia

Molecular Therapy(2025)10.1016/j.ymthe.2025.10.048

N/A

0DataRank · unranked

1 citations

Siddhant Gupte, Emily Xu, Kaitlyn R. Calabro, Hannah Friend, Sean M. Crosson +10 more